Data as Reported: 2024-10
| Month | Contract ID | Vendor | Total Cost | Effective Expiry Date |
Unit(s) | Description |
|---|---|---|---|---|---|---|
| 2024-10 |
aID: CW2243416
|
LIFE TECHNOLOGIES | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2024-05 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2024-04 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2024-03 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2024-02 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2024-01 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2023-12 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-11 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2023-10 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-09 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-08 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-07 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-06 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-05 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2023-04 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-03 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2023-02 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2023-01 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $3,000,000.00 | 2018-02-15 2026-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2022-11 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2022-10 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2022-09 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2022-08 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Blood Grouping and Typing Reagents: Antibody Potentiating Media, Copper Sulfate Solutions, Normal Saline, etc. |
| 2022-07 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2022-06 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2022-04 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2022-03 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| 2022-02 |
aID: CW2243416
|
LIFE TECHNOLOGIES CORPORATION | $2,400,000.00 | 2018-02-15 2023-02-14 |
|
Clinical Laboratory Reagents and Tests (Blood Grouping, Diagnostics, Drug Monitoring, Etc.) |
| CA SoS Registration | C2939511 |
| CA SoS Registration Date | 12/26/2006 |
| CA SoS Registration Jurisdiction | DELAWARE |
| CA SoS Checked | 1632363148038 |
| CA SoS Maybe Dupe | TRUE |
| CA SoS Registration Name | LIFE TECHNOLOGIES CHARITABLE FOUNDATION |
| CA SoS Agent | JOSEPH W SECONDINE, JR. |